(Reuters Health) – Women who are heavy drinkers are at increased risk of pre-menstrual syndrome (PMS), new research shows.
Source: Reuters Medical News
FDA panel against higher dose of Lilly-Incyte arthritis drug
(Reuters) – An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster.
Source: Reuters Medical News
Magnetic fields in electric cars don't seem to cause pacemaker problems
(Reuters Health) – Electromagnetic fields produced by motors in electric cars don’t appear strong enough to interfere with implanted heart devices like pacemakers and defibrillators, a small German study suggests.
Source: Reuters Medical News
Vaping tied to higher risk that teens will try marijuana
(Reuters Health) – Teens who use e-cigarettes may be twice as likely to smoke pot as their peers who never try vaping, a U.S. study suggests.
Source: Reuters Medical News
Wounded soldier gets world's first penis transplant in U.S. operation
(Reuters) – A soldier wounded by an improvised explosive device in Afghanistan has received the world’s first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday.
Source: Reuters Medical News
Gender bias in peer review of research grants may penalize women
(Reuters Health) – Female researchers may be less successful at winning grant funding than their male counterparts with similar experience and qualifications at least in part because of gender bias among reviewers, a Canadian study suggests.
Source: Reuters Medical News
Jilted Akorn sues Fresenius over deal termination
FRANKFURT (Reuters) – U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.
Source: Reuters Medical News
Trump delays drug pricing speech, no set date yet
WASHINGTON (Reuters) – U.S. President Donald Trump has postponed a speech on lowering prescription drug prices previously scheduled for Thursday to a date in the near future, the White House said on Sunday.
Source: Reuters Medical News
Woodford-backed biotech Prothena plunges as key drug fails
LONDON (Reuters) – Shares in Prothena, a biotech company backed by British investor Neil Woodford, plunged 70 percent on Monday after its main drug for treating a rare disease called AL amyloidosis failed in a crucial clinical trial.
Source: Reuters Medical News
FDA declines to approve Pfizer biosimilar of Roche's cancer drug
(Reuters) – Pfizer Inc said on Monday U.S. regulators declined to approve the company’s biosimilar of Roche’s blockbuster treatment for breast cancer, Herceptin, and sought additional technical information.
Source: Reuters Medical News